In addition, we continued to see strong interest frominvestigators for initiating new trials with STA-9090 and expect to launch anumber of new Phase 2 trials in solid tumor indications by the end of the year.More details will be provided closer to trial initiation.” In April, Synta presented pre-clinical data on STA-9090 at the AmericanAssociation of Cancer Research meeting, which demonstrated improved potency ofSTA-9090 compared to other compounds in the Hsp90 inhibitor class and potentactivity in multiple lung cancer models, including those resistant to treatmentwith erlotinib (Tarceva®). We initiated a Phase 1/2,twice-weekly dosing trial in hematologic cancers of STA-9090, our novel,synthetic Hsp90 inhibitor that has shown substantial advantages compared to thefirst generation, ansamycin (17-AAG) family, inhibitors. “We made importantprogress on a number of fronts in this first quarter. In the first quarter of 2009, the Company achieved and was paid a $10 millionnon-refundable operational milestonepayment under the GSK Agreement related tothe development of elesclomol for the treatment of metastatic melanoma. In the first quarter of 2009, the Company recorded $4.5 million of netcollaboration revenues under its existing partnership agreement withGlaxoSmithKline (GSK) and its new partnership agreement with Hoffman-La Roche(Roche), which was entered into in December 2008. LEXINGTON, Mass.–(Business Wire)–Synta Pharmaceuticals Corp. Visit and formore information TransFair USAAnthony Marek, 510-625-2000, ext.

K-Cup® portion packs for Keurig® Single-Cup Brewers areproduced by a variety of licensed roasters, including Green Mountain Coffee andTully`s Coffee. For more information, please visit About Green Mountain Coffee Roasters, Inc. Guests can count oninnovative menu items, including unique cream cheese flavors, deliciousbreakfast sandwiches and wraps, hand-tossed salads, hearty soups, signature andcustom order sandwiches and desserts. BOSTON–(Business Wire)–On the morning of Wednesday, May 13, an estimated 20,000 T riders will berewarded for their environmentally-friendly decision to use publictransportation. For more information, pleasevisit PepsiAmericas, Inc.Sara Zawoyski, 612-661-3830 (Investors)Mary Viola, 847-598-2870 (Press)orJoele Frank, Wilkinson Brimmer KatcherJudith Wilkinson or Jeremy Jacobs, 212-355-4449 (Press) Copyright Business Wire 2009. Fundamentally, theproposal does not reflect the value of PepsiAmericas` strengths and stand-alonestrategies, as evidenced by the Company`s strong first quarter results. MINNEAPOLIS–(Business Wire)–PepsiAmericas, Inc.

For more information, visitFuel Tech`s web site at This press release may contain statements of a forward-looking nature regardingfuture events. Many of Fuel Tech`s products and services rely heavily on the Company`sexceptional Computational Fluid Dynamics modeling capabilities, which areenhanced by internally developed, high-end visualization software. This announcement represents the first new order secured under the 2008 licenseimplementation agreement with EMS in which Fuel Tech`s technology is utilized toimplement programs in Mexico in exchange for license royalty payments based onthe volume of chemical consumed by EMS`s customers John F. has been awarded an order for the installation of three commercial FUELCHEM® programs from Comisión Federal de Electricidad (CFE), the Mexican nationalutility.

This measure should be considered in addition to, and not as a substitute for orsuperior to, any measure of performance prepared in accordance with GAAP.Diamond Management & Technology Consultants, Inc.InvestorContact:Margaret 312-255-5784orMedia Contact:David Copyright Business Wire 2009. RECONCILIATION OF CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW (2):For the Three Months For the YearEnded March 31,Ended March 31, 2008 20092008 2009 (Unaudited)(Unaudited) (Unaudited)(Unaudited)Net cash provided by operating activities $ 2,038 $ 4,723$ 26,001$ 14,600 Capital expenditures(862 )(345 ) (3,066) (1,642)Free cash flow$ 1,176 $ 4,378$ 22,935$ 12,958(2) Free cash flow, defined as net cash provided by operating activities less capital expenditures, is a non-GAAP term. Investors should recognize that Adjusted EBITDA might not be comparable to similarly-titled measures of other companies. Since the greatest value in a strategy, and its highest risk,resides in its implementation, Diamond also provides proven executioncapabilities.